AVPR2: Potential Drug Target for Kidney Diseases (G554)

Target Name: AVPR2

NCBI ID: G554

AVPR2: Potential Drug Target for Kidney Diseases

AVPR2 (Arginine vasopressin receptor 2) is a protein that is expressed in the kidney and has been identified as a potential drug target in the treatment of various kidney diseases. AVPR2 is a member of the family of aquaporin (AQP) proteins, which are involved in water transport and regulation in various body systems. In this article, we will discuss the structure and function of AVPR2, its potential as a drug target, and current research efforts to target this protein.

Structure and Function

AVPR2 is a 22-kDa protein that is expressed in the kidney and has been shown to be involved in the regulation of water and electrolyte balance. The protein is composed of 214 amino acid residues and has a calculated pI of 9.97. AVPR2 is predominantly expressed in the proximal tubules of the kidney, which are responsible for reabsorbing water and electrolytes from the filtrate.

AVPR2 is involved in the regulation of water and electrolyte transport in the kidney through its ability to interact with various signaling molecules. One of the most well-known interactions of AVPR2 is with the neurotransmitter vasopressin (PV), also known as arginine vasopressin (AV). PV is a potent vasoconstrictor that can cause blood vessels to constrict and is involved in the regulation of blood pressure. AVPR2 has been shown to play a critical role in the regulation of AV-dependent signaling pathways, including the regulation of blood pressure and the maintenance of normal kidney function.

In addition to its role in the regulation of AV-dependent signaling pathways, AVPR2 is also involved in the regulation of other signaling pathways that are important for kidney function, including the regulation of inflammation and fibrosis.

Potential Drug Target

The potential drug target for AVPR2 is its role in the regulation of AV-dependent signaling pathways, which are involved in the regulation of various physiological processes in the body. One of the primary goals of targeting AVPR2 is to modulate its activity and reduce its ability to regulate AV signaling pathways.

Current research efforts are focused on identifying small molecules that can inhibit the activity of AVPR2 and modulate its function. These small molecules can be used to develop new treatments for various kidney diseases, including chronic kidney disease, hypertension, and heart failure.

Conclusion

In conclusion, AVPR2 is a protein that is expressed in the kidney and is involved in the regulation of various physiological processes in the body. Its potential as a drug target is based on its involvement in the regulation of AV-dependent signaling pathways, which are involved in the regulation of various physiological processes in the body. Current research efforts are focused on identifying small molecules that can inhibit the activity of AVPR2 and modulate its function, with the goal of developing new treatments for various kidney diseases.

Protein Name: Arginine Vasopressin Receptor 2

Functions: Receptor for arginine vasopressin. The activity of this receptor is mediated by G proteins which activate adenylate cyclase. Involved in renal water reabsorption

More Common Targets